[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07710820":3,"trial-entities:NCT07710820":172,"trial-summary:NCT07710820":175},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":10,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":20,"study_type":24,"primary_purpose":25,"phases":26,"enrollment_info":28,"interventions":31,"primary_outcomes":50,"secondary_outcomes":54,"sex":66,"minimum_age":67,"maximum_age":68,"healthy_volunteers":69,"eligibility_criteria":70,"std_ages":96,"locations":99,"central_contacts":163,"overall_officials":169,"references":170,"see_also_links":171},"NCT07710820","PHI252504","A Multi-Site Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Cigarette Smokers","A Multi-Site Two-Arm Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Combustible Cigarette Smokers","RECRUITING","2026-12","2026-07","2026-07-17","RAI Services Company","INDUSTRY",false,"The goal of this study is to evaluate the rate of end of study complete cigarette reduction in health adult consumers of cigarettes when given access to a heated tobacco product (HTP). The primary study objective is to evaluate the impact of access to HTP Device 1 or HTP Device 2 and a single stick variant on the rate of final 7-day abstinence from smoking cigarettes among U.S. adult smokers at the end of a 3-month study period.","This will be a multi-site, open-label, two-arm study to evaluate the rate of end of study complete combustible cigarette (CC) reduction in healthy adult consumers of CC when given access to a heated tobacco product (HTP) device (glo or glo plus), with one of four variants of HTP consumables (also known as \"sticks\" or \"stick variants\", under the brand name \"virto\") over a 3-month (90-day) actual use period (AUP).",[18,19],"Smoking","Tobacco",[21,18,22,23],"Tobacco Harm Reduction","Tobacco Use","Tobacco Smoking","INTERVENTIONAL","OTHER",[27],"NA",{"count":29,"type":30},1060,"ESTIMATED",[32,38,42,46],{"type":25,"name":33,"description":34,"armGroupLabels":35},"31237616","Tobacco Flavor #1",[36,37],"HTP Device 1","HTP Device 2",{"type":25,"name":39,"description":40,"armGroupLabels":41},"31237617","Tobacco Flavor #2",[36,37],{"type":25,"name":43,"description":44,"armGroupLabels":45},"31237571","Menthol #1",[36,37],{"type":25,"name":47,"description":48,"armGroupLabels":49},"31237581","Menthol #2",[36,37],[51],{"measure":52,"timeFrame":53},"Number and proportion of participants self-reporting past 7-day complete combustible cigarette reduction (abstinence) during the final 7 days of the 3-month (90-day) study period in each study arm and by stick variant within the study arm.","7 days",[55,57,60,62,64],{"measure":56,"timeFrame":53},"The number and proportion of participants who completely switch from combustible cigarette smoking to HTP device 1 or HTP device 2 during the entire final 7 days of the 3 month study period in each study arm and by stick variant within the study arm.",{"measure":58,"timeFrame":59},"The number and proportion of participants who reduce their combustible cigarettes by more than or equal to 50% within their average weekly cigarettes per day from baseline to final 7 days of the study period in each study arm and by stick variant.","3 months",{"measure":61,"timeFrame":59},"The time to first 7-day abstinence of combustible cigarettes by participants in each study arm and by stick variant within each study arm",{"measure":63,"timeFrame":59},"The weekly mean percent cigarettes per day reductions from baseline in each study arm and by stick variant within each arm",{"measure":65,"timeFrame":59},"The number and type of adverse experiences\u002Fevents in relation to use of the Study IP in each study arm and by stick variant within each study arm","ALL","21 Years","65 Years",true,{"inclusion":71,"exclusion":83,"raw_text":95},[72,73,74,75,76,77,78,79,80,81,82],"Able to read, understand, and are willing to sign an Informed Consent Form (ICF) and complete questionnaires written in English.","Generally healthy male or female, between 21 and 65 years of age, inclusive, at the time of consent, verified with government-issued identification.","All female (assigned at birth) candidate participants who agree to take the pregnancy test on site and receive a negative result, and who affirm at the SEV that they are not pregnant or intending to become pregnant. Note: Participants who identify as \"intersex\" or \"unknown\" during screening, will be required to take a pregnancy test if they wish to take one.","Currently smoke at least five combustible cigarettes on smoking days in the past 30 days.","Smoke combustible cigarettes on 15 or more of the past 30 days.","Smoked at least 100 factory-made filtered menthol and\u002For non-menthol combustible cigarettes in their lifetime prior to the Site Enrollment Visit.","Must indicate a neutral\u002Fpositive intention to use at least one stick variant at the Site Enrollment Visit.","Own a smartphone (iOS or Android) with internet access to download a study application to access surveys and the capability to receive notifications.","Agree to participate in the study and to abide by the study restrictions and requirements, as described in the ICF.","Must try all four stick variants during the 1-week product trial period.","Must indicate a neutral\u002Fpositive intention to use at least one stick variant following the product trial period.",[84,85,86,87,88,89,90,91,92,93,94],"Female participants who are pregnant or breastfeeding or planning to become pregnant or start breastfeeding within the next 6 months based on self-report.","Male participants who self-report they are not willing to use a barrier method of contraception (e.g., a condom with spermicide) or refrain from donating sperm from the time of the signing of the ICF until the end of the study, unless they have undergone a vasectomy or are abstinent from heterosexual intercourse, or their female partner was not able to bear children.","Female participants who self-report not using adequate methods to prevent pregnancy.","Persons with pacemakers or other embedded electronic medical devices fitted.","Participants who self-report having an unstable heart condition, severe hypertension, or diabetes.","Individuals who respond with 'Poor' or 'Don't know' to general physical or mental health.","Participants who have used electronic nicotine delivery system (ENDS), nicotine pouches, HTP or smokeless tobacco (i.e., chewing tobacco, snus, or snuff) products, other combustible tobacco\u002Fnicotine products, and other oral nicotine products (tablets, gums, and lozenges) on 5 or more days in the past 30 days.","Participants who have used a nicotine replacement therapy (NRT) product or a prescription drug to help stop smoking (e.g., varenicline, bupropion) in the past 30 days.","Employee of a company that manufactures tobacco or HTPs.","Persons who are personally, have household members, or have close family or friends in litigation with a company that manufactures tobacco or HTPs.","Have taken part in a tobacco\u002Fnicotine research study in the past 30 days.","Inclusion Criteria:\n\n* Able to read, understand, and are willing to sign an Informed Consent Form (ICF) and complete questionnaires written in English.\n* Generally healthy male or female, between 21 and 65 years of age, inclusive, at the time of consent, verified with government-issued identification.\n* All female (assigned at birth) candidate participants who agree to take the pregnancy test on site and receive a negative result, and who affirm at the SEV that they are not pregnant or intending to become pregnant. Note: Participants who identify as \"intersex\" or \"unknown\" during screening, will be required to take a pregnancy test if they wish to take one.\n* Currently smoke at least five combustible cigarettes on smoking days in the past 30 days.\n* Smoke combustible cigarettes on 15 or more of the past 30 days.\n* Smoked at least 100 factory-made filtered menthol and\u002For non-menthol combustible cigarettes in their lifetime prior to the Site Enrollment Visit.\n* Must indicate a neutral\u002Fpositive intention to use at least one stick variant at the Site Enrollment Visit.\n* Own a smartphone (iOS or Android) with internet access to download a study application to access surveys and the capability to receive notifications.\n* Agree to participate in the study and to abide by the study restrictions and requirements, as described in the ICF.\n* Must try all four stick variants during the 1-week product trial period.\n* Must indicate a neutral\u002Fpositive intention to use at least one stick variant following the product trial period.\n\nExclusion Criteria:\n\n* Female participants who are pregnant or breastfeeding or planning to become pregnant or start breastfeeding within the next 6 months based on self-report.\n* Male participants who self-report they are not willing to use a barrier method of contraception (e.g., a condom with spermicide) or refrain from donating sperm from the time of the signing of the ICF until the end of the study, unless they have undergone a vasectomy or are abstinent from heterosexual intercourse, or their female partner was not able to bear children.\n* Female participants who self-report not using adequate methods to prevent pregnancy.\n* Persons with pacemakers or other embedded electronic medical devices fitted.\n* Participants who self-report having an unstable heart condition, severe hypertension, or diabetes.\n* Individuals who respond with 'Poor' or 'Don't know' to general physical or mental health.\n* Participants who have used electronic nicotine delivery system (ENDS), nicotine pouches, HTP or smokeless tobacco (i.e., chewing tobacco, snus, or snuff) products, other combustible tobacco\u002Fnicotine products, and other oral nicotine products (tablets, gums, and lozenges) on 5 or more days in the past 30 days.\n* Participants who have used a nicotine replacement therapy (NRT) product or a prescription drug to help stop smoking (e.g., varenicline, bupropion) in the past 30 days.\n* Employee of a company that manufactures tobacco or HTPs.\n* Persons who are personally, have household members, or have close family or friends in litigation with a company that manufactures tobacco or HTPs.\n* Have taken part in a tobacco\u002Fnicotine research study in the past 30 days.",[97,98],"ADULT","OLDER_ADULT",[100,109,116,124,130,138,141,149,156],{"facility":101,"status":8,"city":102,"state":103,"zip":104,"country":105,"geoPoint":106},"Opinions Brandon","Brandon","Florida","33511","United States",{"lat":107,"lon":108},27.9378,-82.28592,{"facility":110,"status":8,"city":111,"state":103,"zip":112,"country":105,"geoPoint":113},"Opinions Coral Springs","Coral Springs","33071",{"lat":114,"lon":115},26.27119,-80.2706,{"facility":117,"status":8,"city":118,"state":119,"zip":120,"country":105,"geoPoint":121},"Opinions Chicago","Aurora","Illinois","60504",{"lat":122,"lon":123},41.76058,-88.32007,{"facility":117,"status":8,"city":125,"state":119,"zip":126,"country":105,"geoPoint":127},"Gurnee","60031",{"lat":128,"lon":129},42.3703,-87.90202,{"facility":131,"status":8,"city":132,"state":133,"zip":134,"country":105,"geoPoint":135},"Opinions Las Vegas","Las Vegas","Nevada","89107",{"lat":136,"lon":137},36.17497,-115.13722,{"facility":131,"status":8,"city":132,"state":133,"zip":139,"country":105,"geoPoint":140},"89119",{"lat":136,"lon":137},{"facility":142,"status":8,"city":143,"state":144,"zip":145,"country":105,"geoPoint":146},"Opinions Fort Worth","Fort Worth","Texas","76132",{"lat":147,"lon":148},32.72541,-97.32085,{"facility":150,"status":8,"city":151,"state":144,"zip":152,"country":105,"geoPoint":153},"Opinions Houston","Houston","77070",{"lat":154,"lon":155},29.76328,-95.36327,{"facility":157,"status":8,"city":158,"state":144,"zip":159,"country":105,"geoPoint":160},"Opinions Dallas","Hurst","76053",{"lat":161,"lon":162},32.82346,-97.17057,[164],{"name":165,"role":166,"phone":167,"email":168},"Emily Smith","CONTACT","336-741-2396","smithe13@rjrt.com",[],[],[],{"nct_id":4,"conditions":173,"biomarkers":174},[18],[],{"nct_id":4,"found":69,"summary":176,"prompt_version":186},{"design":177,"status":178,"heading":179,"summary":180,"follow_up":181,"word_count":182,"commitments":183,"compensation":184,"drugs_mentioned":185},"This is an open-label study, meaning you and the researchers will know which heated tobacco product you are using. It involves about 1060 participants and has two groups.","completed","Study of Heated Tobacco Products for Smoking Abstinence","This study is looking at whether using a heated tobacco product (HTP) can help current cigarette smokers quit. Researchers want to see if giving people access to either HTP Device 1 or HTP Device 2, along with one of four tobacco flavors (Tobacco Flavor #1, Tobacco Flavor #2, Menthol #1, or Menthol #2), helps them stop smoking regular cigarettes. The main goal is to see how many participants report not smoking any regular cigarettes during the last 7 days of the 3-month study. You can join if you are a generally healthy adult between 21 and 65 years old and currently smoke cigarettes. The current status of this study is unclear.","The primary measurement for the study is taken during the final 7 days of the 3-month study period.",111,"You would use a heated tobacco product for a 3-month (90-day) period and complete questionnaires. The study will measure your cigarette use at the end of this period.","Not stated in the trial record.",[],"v2"]